Drug intelligence / Profile preview

autologous volar fibroblasts

Development stage
Unknown
Lead developer
Stanford University
Modality
Cell Therapies
Administration
Intradermal
01

Overview

Autologous volar fibroblasts are an investigational autologous cell therapy consisting of a patient's own fibroblasts harvested from volar skin sites, such as the palms of the hands or the soles of the feet. These specialized fibroblasts are unique because they maintain a site-specific 'positional memory' governed by distinct Homeobox (HOX) gene expression patterns, which persists even after expansion in vitro. When transplanted or injected into non-volar body sites, these cells signal the overlying epidermis to undergo a transition toward a volar phenotype, characterized by a thickened stratum corneum and the absence of hair follicles. This therapeutic approach is primarily being evaluated in the context of reconstructive surgery to improve the durability and functional integration of skin grafts or to treat conditions where the restoration of specialized skin properties is required. The therapy aims to leverage the cells' inherent biological signaling to modify the local tissue environment and improve clinical outcomes for patients with significant scarring or skin loss.

Other names
Volar fibroblastsAutologous palmoplantar fibroblasts

Beyond the preview

Go deeper on autologous volar fibroblasts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous volar fibroblasts.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call